Name Funds
holding
Growth Growth % Return since
30 Jun ‘22
901
71 +2 +3% 34.5%
902
72 +2 +3% 20.5%
903
36 +1 +3% 47.8%
AIM
904
AIM ImmunoTech
AIM
$3.94M
36 +1 +3% 98.5%
905
73 +2 +3% 99.8%
906
74 +2 +3% 9.32%
907
37 +1 +3% 52.5%
908
37 +1 +3% 30.5%
909
37 +1 +3% 14.5%
910
37 +1 +3% 68.2%
OTLK icon
911
Outlook Therapeutics
OTLK
$33.3M
75 +2 +3% 97.5%
912
115 +3 +3% 29.8%
913
39 +1 +3% 41.5%
914
82 +2 +3% 73.3%
915
42 +1 +2% 1.92%
916
42 +1 +2% 91.8%
917
43 +1 +2% 32.5%
918
43 +1 +2% 1.59%
919
43 +1 +2% 17.9%
920
44 +1 +2% 42.5%
921
44 +1 +2% 33%
922
44 +1 +2% 12.2%
923
44 +1 +2% 99.8%
924
44 +1 +2% 30.2%
925
45 +1 +2% 5.77%